Compare IZEA & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IZEA | ARAY |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | United States |
| Employees | 75 | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.9M | 42.3M |
| IPO Year | 2010 | 2006 |
| Metric | IZEA | ARAY |
|---|---|---|
| Price | $4.45 | $0.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 71.0K | ★ 1.5M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,099,695.00 | N/A |
| Revenue This Year | $20.81 | N/A |
| Revenue Next Year | $14.86 | $4.58 |
| P/E Ratio | $54.43 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.70 | $0.33 |
| 52 Week High | $5.86 | $2.10 |
| Indicator | IZEA | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 69.73 | 52.19 |
| Support Level | $4.31 | $0.34 |
| Resistance Level | $4.74 | $0.63 |
| Average True Range (ATR) | 0.21 | 0.05 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 83.62 | 90.00 |
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.